pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Former FDA commissioners slam current HHS leadership over research cuts and regulatory challenges

Oct 15, 2026·read at STAT ↗RegulatoryNegative

Former FDA commissioners Rob Califf, Scott Gottlieb and Ned Sharpless publicly criticized the officials running the agency, saying the current HHS leadership is failing the FDA.

They highlighted massive challenges such as cuts to curiosity-driven research and funding, and warned that upcoming AI regulation could further strain the agency.

The remarks appeared in a STAT Plus newsletter article by John Wilkerson on Oct. 15, 2026, alongside coverage of the STAT Summit's focus on biotech innovation and drug-pricing policy.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Former FDA commissioners Califf, Gottlieb, Sharpless lay into current HHS leadership”

read at STAT ↗
493 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Cystic FibrosisInfectious DiseaseOncology

related stories

  • 3h agoGSK laying off 1.2K+ in BelgiumBioSpace
  • Sep 3Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readoutFierce Biotech
  • Sep 1Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?Fierce Biotech
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 18Ebola cases increase almost 40% in a week as death toll passes 200STAT